Monday, August 18, 2025
HomeTagsHealthcare

Healthcare

Frontier Biotechnologies Announces Positive Phase 1 Results of Coronavirus

Frontier Biotechnologies, a biopharmaceutical company focused on the discovery, development and dissemination of innovative medicines that improve patient health, announced positive results from the...

Imspex Diagnostics announces BreathSpec Instrument

Imspex Diagnostics Ltd announced that it has received CE mark for its BreathSpec instrument for the detection of COVID-19 using non-invasive breath testing and...

ImmVira’s Brand New oHSV Product MVR-C5252 Targeting Malignant Glioma

U.S. time, ImmVira's brand new oncolytic herpes simplex virus ("oHSV") product MVR-C5252 targeting Malignant Glioma has obtained Orphan Drug Designation ("ODD") from U.S. Food...

U.S. FDA Approves Additional Indication of Darolutamide in Combination With Docetaxel

Orion’s collaboration partner Bayer announced the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for the oral androgen...

Ascletis Announces First Patient Dosed in the U.S. Phase I Clinical Trial of Oral PD-L1

Ascletis Pharma Inc. announces the completion of first patient dosing in the U.S. Phase I clinical trial of ASC61, an oral PD-L1 small molecule...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics